Literature DB >> 22659943

[Total mesorectal excision with and without preoperative radiotherapy for patients with resectable rectal cancer: The multicentre, randomised controlled TME trial 12-year follow-up].

H A Wolff1, T Liersch.   

Abstract

Entities:  

Year:  2012        PMID： 22659943     DOI： 10.1007/s00066-012-0132-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications.

Authors:  Hendrik Andreas Wolff; Daniela Melanie Wagner; Lena-Christin Conradi; Steffen Hennies; Michael Ghadimi; Clemens Friedrich Hess; Hans Christiansen
Journal:  Radiother Oncol       Date:  2011-11-21       Impact factor: 6.280

2.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

Review 3.  [Individualizing treatment for locally advanced rectal cancer].

Authors:  T Liersch; H Rothe; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

Review 4.  Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?

Authors:  Claus Rödel; Dirk Arnold; Heinz Becker; Rainer Fietkau; Michael Ghadimi; Ullrich Graeven; Clemens Hess; Ralf Hofheinz; Werner Hohenberger; Stefan Post; Rudolf Raab; Rolf Sauer; Frederick Wenz; Torsten Liersch
Journal:  Strahlenther Onkol       Date:  2010-11-30       Impact factor: 3.621

5.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

6.  Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer.

Authors:  B Michael Ghadimi; Marian Grade; Torsten Liersch; Claus Langer; Alexander Siemer; László Füzesi; Heinz Becker
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

7.  A special device (double-hole belly board) and optimal radiation technique to reduce testicular radiation exposure in radiotherapy of rectal cancer.

Authors:  Hilke Vorwerk; Robert Michael Hermann; Hans Christiansen; Thorsten Liersch; Clemens Friedrich Hess; Elisabeth Weiss
Journal:  Radiother Oncol       Date:  2007-08-13       Impact factor: 6.280

8.  Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer.

Authors:  Hilke Vorwerk; Thorsten Liersch; Hilka Rothe; Michael Ghadimi; Hans Christiansen; Clemens Friedrich Hess; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621
  8 in total
  1 in total

1.  Rectal cancer: multimodal treatment approach.

Authors:  Manousos-Georgios Pramateftakis; Dimitrios Kanellos; Paris P Tekkis; Nikolaos Touroutoglou; Ioannis Kanellos
Journal:  Int J Surg Oncol       Date:  2012-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.